Asia-Pacific Digital Respiratory Device Market Overview:

According to MarkNtel Advisors study the Asia-Pacific Digital Respiratory Device Market is projected to grow at a CAGR of around 36.2% during the forecast period, i.e., 2023-28. Most of the market expansion attributes to the mounting instances of respiratory diseases, including asthma, chronic obstructive pulmonary disease, and sleep apnea resulting in the frequent adoption of the digital technology-enabled medical device. Besides, the region’s widespread presence of other respiratory diseases, such as chronic bronchitis, emphysema, and wheezing, has swiftly augmented the demand for digital respiratory devices. For instance, per the research study titled” Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modeling study”, South East Asia Region had the most significant global cases of current wheezing, with 200.57million in 2019, The age group that contributed the most was 30-34 years in West Pacific region. The countries with the most cases of current wheezing globally were China and India.

Key Findings of the Study: Asia-Pacific Digital Respiratory Device market

Asia-Pacific Digital Respiratory Device Market Growth Opportunity:

Favorable Regulatory Standards for Digital Interventions and Strategies in The Healthcare Ecosystem – In order to handle the large amount of data generated during diagnosis and treatment procedure paired with health status, efficient regulations by the government have been realizing in the past few years. The APAC region’s regulatory review procedures are expected to be more consistent and predictable because of the convergence of digital health regulations, which will elevate the delivery of new, safe, and effective digital health solutions to patients and medical professionals. Furthermore, the establishment of regulatory pathways designed specifically to meet the requirements of digitalized medical products would encourage innovation, which will be advantageous to both developers and patients.

In case you missed it, we are currently revising our reports. Click on the “request sample report“ button to get the latest research data with forecast for the years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Scope of the Asia-Pacific Digital Respiratory Device Market Report Segmentation

-By Device Type

• Therapeutic Devices
• Diagnostics Monitoring Devices
• Consumables and Accessories
• Respiratory Therapy Wearable Medical Device
• Disposables

-By End-User

• Homecare
• Hospitals and Clinics
• Ambulatory Care Centers

-By Application

• Chronic Obstructive Pulmonary Disease
• Sleep Apnea
• Asthma
• Infectious Disease

For more detailed information about the Asia-Pacific Digital Respiratory Device market report, click here – https://www.marknteladvisors.com/research-library/asia-pacific-digital-respiratory-device-market.html

Geographical analysis:

-By Country

• China
• India
• Japan
• Australia
• New Zealand
• South Korea
• Rest of Asia-Pacific

Country-wise, China garnered the lion’s share of the Digital Respiratory Device Market across Asia Pacific in the historical period. The outbreak of Covid -19 and the ever-increasing aging population have been the prominent factors backing the steady adoption of such devices here. It also owes to the growing prevalence of asthma, which has been an economic and social burden for children and guardians for the past three decades. As such, China announced its first health initiative, Healthy China 2030, which seeks to improve the national health system. Such initiatives would further propel the demand for smart and effective medical devices in the long run. Moreover, Medical informatics research in China has AI as a competing arena focusing on diagnostic deep-learning algorithms for medical imaging.

Asia-Pacific Digital Respiratory Device Industry Recent Developments

• In November 2022, Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. declared a new collaboration with HealthSnap, a leading full-service Virtual Care Management Platform for chronic disease management.
• In Feb 2022, Astra Zeneca Plc. and Honeywell came into a partnership to develop next-generation respiratory inhalers via the propellant HFO-1234ze, which has up to 99.9% less global warming potential (GWP) than propellants currently used in respiratory medicines.

Current Landscape of Asia-Pacific Digital Respiratory Device Market

The report delineates key market participants and thoroughly assesses their strategic approaches, trends, innovations, and manufacturing infrastructure, enabling a forecast of their market impact over the next five years. The meticulously researched data presented holds the potential to distinguish even nascent market entrants in the long term. Armed with pertinent data and actionable insights, our research report delivers a comprehensive overview of the market, empowering investors and stakeholders to establish a robust presence in the Asia-Pacific Digital Respiratory Device market. The research report profiles major players, including

Customization of Reports Available – https://www.marknteladvisors.com/query/request-customization/asia-pacific-digital-respiratory-device-market.html

• Philips
• 3M Healthcare
• Astra Zenca Plc.
• Novartis AG
• GE Healthcare
• Masimo Corporation
• Cipla Ltd.
• Resmed Ltd.
• Teva Pharmaceuticals Industries Ltd.
• Acorda Therapeutics

Related Reports

• https://fox2now.com/business/press-releases/ein-presswire/4.6294444.684.6/luxury-furniture-market-valued-at-around-usd-24.6-65-billion-in-2024.6-set-to-reach-around-usd-41-95-billion-by-204.60
• https://www.wvnstv.com/business/press-releases/ein-presswire/4.6294444.684.6/luxury-furniture-market-valued-at-around-usd-24.6-65-billion-in-2024.6-set-to-reach-around-usd-41-95-billion-by-204.60
• https://www.upmatters.com/business/press-releases/ein-presswire/4.6294444.684.6/luxury-furniture-market-valued-at-around-usd-24.6-65-billion-in-2024.6-set-to-reach-around-usd-41-95-billion-by-204.60
• https://www.themarketingcommunicator.com/article/4.6294444.684.6-luxury-furniture-market-valued-at-around-usd-24.6-65-billion-in-2024.6-set-to-reach-around-usd-41-95-billion-by-204.60
• https://www.informnny.com/business/press-releases/ein-presswire/4.6294444.684.6/luxury-furniture-market-valued-at-around-usd-24.6-65-billion-in-2024.6-set-to-reach-around-usd-41-95-billion-by-204.60

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India